A method for predicting which ovarian cancer patients are unlikely to benefit from chemotherapy was discovered by researchers from the Icahn School of Medicine at Mount Sinai in New York City, according to a study published in Cell Aug. 3.
Read the full post on Becker's Hospital Review - Healthcare News
